Finance

Lists
Why is KYMR up 2,84%?
Dive Deeper
KYMR:NASDAQ
Kymera Therapeutics Inc
112,40 US$
+2,84%
(+3,10) 1D
112,40 US$
0,00% (0,00)
After hours
Closed: 9 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KYMR...
Open
109,54 US$
High
115,82 US$
Low
107,46 US$
Mkt. cap
9,35 მლრდ.
Avg. vol.
779,23 ათ.
Volume
1,31 მლნ.
52-wk high
130,05 US$
52-wk low
55,26 US$
EPS
-3,24 US$
Beta
1,98
Shares outstanding
83,15 მლნ.
No. of employees
273
Open
109,54 US$
High
115,82 US$
Low
107,46 US$
Mkt. cap
9,35 მლრდ.
Avg. vol.
779,23 ათ.
Volume
1,31 მლნ.
52-wk high
130,05 US$
52-wk low
55,26 US$
EPS
-3,24 US$
Beta
1,98
Shares outstanding
83,15 მლნ.
No. of employees
273
News stories
From web sources and news partners
About Kymera Therapeutics Inc
CEO-
Employees273
Founded2015
HeadquartersWatertown, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websitekymeratx.com
Analyst ratings
Based on 16 analysts giving stock ratings to KYMR in the past 3 months
Strong buy
Buy
14
Hold
2
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for KYMR in the last 3 months.
Highest
Current 112,40 US$
180,00 US$ (+60,14%)
Average
141,50 US$ (+25,89%)
Lowest
112,00 US$ (-0,36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Raymond James
Buy
Initiated
140,00 US$
+24,6%
10/08/2026
Geoff Meacham
Citi
Buy
Maintained
150,00 US$
+33,5%
10/05/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
140,00 US$
+24,6%
09/28/2026
Biren Amin
Piper Sandler
Buy
Maintained
140,00 US$
+24,6%
09/23/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
152,00 US$
+35,2%
09/22/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
144,00 US$
+28,1%
09/14/2026
Andy Chen
Wolfe Research
Buy
Upgraded
180,00 US$
+60,1%
09/10/2026
Brian Abrahams
RBC Capital
Hold
Maintained
112,00 US$
-0,4%
09/02/2026
Bradley Canino
Guggenheim
Buy
Reiterated
170,00 US$
+51,2%
08/30/2026
Derek Archila
Wells Fargo
Buy
Reiterated
151,00 US$
+34,3%
08/27/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
135,00 US$
+20,1%
08/06/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
129,00 US$
+14,8%
08/06/2026
David Dai
UBS
Buy
Maintained
128,00 US$
+13,9%
08/05/2026
Andrew Fein
H.C. Wainwright
Buy
Maintained
134,00 US$
+19,2%
08/06/2026
Eliana Merle
Barclays
Buy
Maintained
139,00 US$
+23,7%
08/06/2026
David Hoang
Deutsche Bank
Hold
Initiated
120,00 US$
+6,8%
07/29/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
140,00 US$
+24,6%
07/16/2026
Daniel Giraldo
Bank of America Securities
Buy
Reiterated
125,00 US$
+11,2%
06/29/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
136,00 US$
+21%
06/29/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
155,00 US$
+37,9%
06/29/2026
Unknown Analyst
B. Riley Securities
Buy
Maintained
155,00 US$
+37,9%
06/26/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
116,00 US$
+3,2%
06/26/2026
Jeet Mukherjee
BTIG
Buy
Maintained
134,00 US$
+19,2%
06/25/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/05/2026
Kelly Shi
Jefferies
Buy
Initiated
110,00 US$
-2,1%
03/15/2026
Faisal Khurshid
Jefferies
Buy
Initiated
110,00 US$
-2,1%
03/15/2026
Sudan Loganathan
Stephens
Buy
Maintained
100,00 US$
-11%
03/02/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
120,00 US$
+6,8%
02/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,76 მლნ.
2,87 მლნ.
34,36 მლნ.
65,00 მლნ.
Cost of goods sold
74,09 მლნ.
83,83 მლნ.
98,16 მლნ.
119,48 მლნ.
Cost of revenue
74,09 მლნ.
83,83 მლნ.
98,16 მლნ.
119,48 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17,34 მლნ.
16,94 მლნ.
20,36 მლნ.
21,13 მლნ.
Operating expense
17,34 მლნ.
16,94 მლნ.
20,36 მლნ.
21,13 მლნ.
Total operating expenses
91,43 მლნ.
100,77 მლნ.
118,52 მლნ.
140,61 მლნ.
Operating income
-88,67 მლნ.
-97,90 მლნ.
-84,15 მლნ.
-75,61 მლნ.
Other non operating income
-
-
5,00 ათ.
-25,00 ათ.
EBT including unusual items
-82,18 მლნ.
-86,98 მლნ.
-69,23 მლნ.
-61,21 მლნ.
EBT excluding unusual items
-78,32 მლნ.
-86,98 მლნ.
-69,23 მლნ.
-61,21 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-82,18 მლნ.
-86,98 მლნ.
-69,23 მლნ.
-61,21 მლნ.
Net profit margin
-2 973,05%
-3 030,70%
-201,47%
-94,17%
Earnings per share
-0,94
-0,98
-0,71
-0,62
Interest and investment income
10,44 მლნ.
11,00 მლნ.
14,98 მლნ.
14,48 მლნ.
Interest expense
-98,00 ათ.
-90,00 ათ.
-66,00 ათ.
-56,00 ათ.
Net interest expenses
10,35 მლნ.
10,92 მლნ.
14,92 მლნ.
14,42 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-85,82 მლნ.
-97,46 მლნ.
-82,13 მლნ.
-74,48 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები